Introduction {#s1}
============

A dualistic concept of cardiovascular and respiratory systems still prevails. However, the fundamental organizational precept of cardiorespiratory control may be viewed as a unitary system. Accumulating evidence strongly supports the notion that these systems imperatively operate in a coordinated way to match the processes of pulmonary ventilation and tissue perfusion (Hayano et al., [@B75]; Giardino et al., [@B61]; Ben-Tal et al., [@B22]). Recordings of parasympathetic and sympathetic nerves supplying the heart and blood vessels indicate that the autonomic activity controlling cardiac output and vascular resistance displays robust patterns of discharge entrained with the respiratory cycle (Adrian et al., [@B5]; Malpas, [@B100]; Barman and Gebber, [@B19]; Bouairi et al., [@B29]; Gilbey, [@B62]; Grossman and Taylor, [@B68]). As a consequence, the respiratory-related modulation of cardiovascular parasympathetic and sympathetic activities produces rhythmical oscillations in baseline heart rate (respiratory sinus arrhythmia) and arterial pressure levels (Traube-Hering waves) (Moraes et al., [@B119]). The pattern of respiratory modulation of autonomic activity modifies according to the metabolic demand (blood gas changes, for instance) and contributes to generate appropriate respiratory and cardiovascular reflex responses (Dick et al., [@B49]; Molkov et al., [@B114]). Therefore, it is undeniable that the respiratory and cardiovascular systems establish interactions to form a unique and dynamic system. In this review, we discuss the potential neuronal sources underpinning the coupling of cardiovascular and respiratory activities, with special attention to the neurons of the nucleus of the solitary tract (NTS), which, due to their anatomical, neurochemical and electrophysiological properties, allow the processing of characteristic, often coupled, patterns of respiratory and autonomic responses to specific physiological and pathological mechanisms.

Respiratory-sympathetic coupling: ventromedullary neurons and beyond
====================================================================

Over the last decades, efforts have been made to identify the cellular sources and neurochemical mechanisms responsible for the cardiorespiratory coupling. Several studies have focused on the interaction between respiratory and sympathetic activities due to its relevance in the control of arterial pressure and its contribution to the development of arterial hypertension (Zoccal et al., [@B168]; Simms et al., [@B146]; Toney et al., [@B157]). Although the pattern of respiratory-sympathetic coupling may vary according to the animal species, experimental condition (for instance, the presence of anesthesia) and the nerve recorded (Malpas, [@B100]), baseline sympathetic nerve activity to blood vessels in mammals exhibits phasic bursts that emerge during inspiratory/post-inspiratory phase (Zhou and Gilbey, [@B164]; Dick et al., [@B49]; Zoccal et al., [@B168]). Part of the respiratory oscillations of sympathetic activity is associated with cyclic stimulation of peripheral afferent receptors, including arterial baroreceptors and pulmonary stretch receptors (Bernardi et al., [@B24]). However, the respiratory rhythmicity of sympathetic activity persists after vagotomy and decerebration (Barman and Gebber, [@B18]), indicating that the coupling of respiratory and sympathetic activities is generated within the brainstem due to connections between neurons of sympathetic and respiratory systems.

The ventral surface of the medulla oblongata has been pointed out as the main site of synaptic interactions between respiratory and sympathetic neurons. The ventral medulla houses the pre-sympathetic neurons of the rostral ventrolateral medulla (RVLM)---the major source of excitatory inputs to the pre-ganglionic sympathetic neurons of the spinal cord that maintain baseline arterial pressure in adequate levels (Guertzenstein and Silver, [@B69]; Ross et al., [@B135]). Intermingled with the RVLM neurons are the respiratory neurons of the ventral respiratory column (VRC), which are considered the kernel of respiratory rhythm and pattern generator (Smith et al., [@B148], [@B147]; Moraes et al., [@B115]). The VRC is composed by four distinct sub-nuclei: Bötzinger complex (BötC), pre-Bötzinger complex (pre-BötC), rostral ventral respiratory group (rVRG) and caudal ventral respiratory group (cVRG) (Bianchi et al., [@B25]). Due to their anatomical proximity, it has been suggested that the respiratory neurons of the ventral medulla establish synaptic connections with the pre-sympathetic neurons of the RVLM and generate the respiratory oscillation in the sympathetic activity (McAllen, [@B105]; Haselton and Guyenet, [@B74]; Zhou and Gilbey, [@B164]; Miyawaki et al., [@B112]; Zoccal et al., [@B168]).

Recent studies performing intracellular recordings of the RVLM pre-sympathetic neurons using the *in situ* preparation of rats identified different populations of C1 and non-C1 neurons that exhibit spontaneous excitatory or inhibitory post-synaptic potentials phase-locked with the respiratory cycle (Moraes et al., [@B116]), thus supporting the notion that the RVLM is an important site of respiratory input convergence (Haselton and Guyenet, [@B74]; Miyawaki et al., [@B112]). In addition to the RVLM, the GABAergic neurons of the caudal ventrolateral medulla (CVLM), which establish synaptic inputs with the RVLM neurons and provide the tonic inhibitory baroreflex control of sympathetic activity (Schreihofer and Guyenet, [@B141]), also display distinct firing patterns coupled to the respiratory cycle (Mandel and Schreihofer, [@B101]). Therefore, there is convincing evidence that the pre-sympathetic neurons of the RVLM, either directly or indirectly through the CVLM, receive the respiratory inputs necessary for the generation of respiratory modulation of sympathetic activity. On the other hand, there are limited data on the literature suggesting the sources of respiratory inputs to the sympathetic neurons of the ventral medulla. Based on the fact the RVLM and CVLM neurons exhibit distinct respiratory-related patterns of discharge (inspiratory peak, post-inspiratory peak and inspiratory depression) (Haselton and Guyenet, [@B74]; Mandel and Schreihofer, [@B101]; Moraes et al., [@B116]), it is possible to speculate that both inspiratory and expiratory neurons of the VRC may establish excitatory and inhibitory synapses with the sympathetic neurons. In agreement with this idea, anatomical studies have evidenced axon varicosities from the BötC neurons closely apposed to the RVLM neurons, strongly suggesting synaptic contacts between these two neuronal populations (Sun et al., [@B153]). Studies showing that ponto-medullary transection eliminated baseline respiratory-sympathetic coupling also suggest that the respiratory neurons of the pons, which send projections to ventromedullary regions (Dobbins and Feldman, [@B50]; Kubo et al., [@B91]), may contribute to baseline respiratory-sympathetic coupling (Baekey et al., [@B15]).

In addition to the lack of clear anatomical and functional data showing the neural substrates responsible for the generation of respiratory modulation of sympathetic outflow at resting conditions (eupnea), changes in the respiratory pattern modify the pattern of respiratory-sympathetic coupling. For instance, peripheral chemoreceptor activation by cytotoxic (with cyanide) or hypoxic hypoxia reflexly induces marked increases in inspiratory and expiratory motor activities combined with a sympatho-excitatory response (Braga et al., [@B32]; Moraes et al., [@B117]). This increase in sympathetic activity is characterized by the emergence of high amplitude bursts during the post-inspiratory phase (Dick et al., [@B49]; Mandel and Schreihofer, [@B102]; Costa-Silva et al., [@B41])---a discharge pattern different from that observed at baseline conditions (Figure [1](#F1){ref-type="fig"}). Changes in the respiratory pattern and in the respiratory-sympathetic coupling are also observed in conditions of hypercapnia, which causes an increase in the sympathetic activity during the late part of expiratory period (prior to the phrenic burst) coupled with the generation of active expiratory pattern (Boczek-Funcke et al., [@B26]; Molkov et al., [@B114]). Therefore, multiple synaptic interactions may exist between respiratory and sympathetic neurons, and either the recruitment or the strengthening of these interactions essentially depends on the activation of neurons regulating the respiratory pattern.

![**Respiratory-sympathetic coupling at basal conditions and during peripheral chemoreflex activation**. Raw and integrated (⨛) recordings obtained in a decerebrated, arterially-perfused *in situ* rat preparation (for details, please see Zoccal et al., [@B168]) showing the coupling of phrenic (PN) and thoracic sympathetic nerve activity (SN) at basal conditions (normocapnia) and during peripheral chemoreflex activation, evoked by intra-arterial administration of potassium cyanide (0.05%, 50 μL; arrow). The shaded gray area delimitates the inspiratory phase (I; coincident with phrenic burst) while the phrenic burst interval correspond to expiratory phase (E).](fphys-05-00238-g0001){#F1}

Accordingly, in spite of the unquestionable role of the ventro-medullary neurons on the control and integration of respiratory and sympathetic activities, other brain areas must be considered as critical pieces of the circuitry regulating the coupling of respiratory and sympathetic activities. In this scenario, the neurons of the nucleus of the solitary tract (NTS) may play a relevant role for the coordination of the respiratory and sympathetic activities, especially in conditions of metabolic challenges, probably by acting as an integrative center to promote the activation of specific pathways due to the combination of neurochemical and neuroanatomical features.

The NTS circuitry and its integrative role
==========================================

The NTS is formed by heterogeneous groups of neurons located in the dorsolateral medulla, extending from the level of caudal portion of the facial nucleus to the caudal portion of the pyramidal decussation (Loewy, [@B95]; Dampney, [@B45]). Previous studies have demonstrated that the NTS plays a key role in the processing of visceral afferent information and transmission to other nuclei in the brainstem, forebrain and spinal cord (for review, see Andresen and Kunze, [@B11]; Sapru, [@B137]; Johnson and Thunhorst, [@B81]; Grill and Hayes, [@B67]). With respect to the cardiovascular and respiratory systems, the majority of the cardiorespiratory afferents converges preferentially to two different regions of the NTS: the intermediate NTS (iNTS), at the level of the area postrema, and the caudal NTS (cNTS), located caudal to the *calamus scriptorius* (Kumada et al., [@B92]; Loewy, [@B95]; Van Giersbergen et al., [@B158]). There is evidence supporting the notion that the iNTS and cNTS 2nd-order neurons are organized in clusters according to the afferent sensory information that they received. For instance, the neurons of the iNTS receive mainly afferent information from the arterial baroreceptors and from the slow-adapting pulmonary stretch receptors (SARs) whilst afferent inputs from peripheral chemoreceptors and rapid-adapting pulmonary stretch receptors (RARs) converge to the neurons of the cNTS (Mifflin et al., [@B111]; Mifflin, [@B109]; Machado, [@B96]; Kubin et al., [@B90]). Therefore, depending on the sensory information, distinct groups of NTS 2nd-order neurons are activated in order to recruit specific efferent pathways (Aicher et al., [@B7]; Bailey et al., [@B17]; Alheid et al., [@B9]; Song et al., [@B150]).

In association with the afferent-oriented organization, several bioactive molecules were identified in the NTS region, including amino acids (L-glutamate, GABA, glycine), biogenic amines (noradrenaline, serotonin, acetylcholine), purines (ATP and ADP) and peptides (angiotensin II, vasopressin, oxytocin), with relevant role in the neurotransmission and neuromodulation (for review, see Andresen and Kunze, [@B11]). These substances may act either post-synaptically or exert their function on pre-synaptic terminals modulating the release of other transmitters (Andresen and Yang, [@B12]; Shigetomi and Kato, [@B144]; Peters et al., [@B127]). Moreover, distinct 2nd-order neurons of the NTS exhibit different electrophysiological properties (De Castro et al., [@B46]; Doyle et al., [@B51]; Accorsi-Mendonca et al., [@B3]) that may contribute to differential timing control of the viscera-sensory information.

The combination of anatomical, neurochemical and electrophysiological features of the NTS neurons allow that this nucleus selectively integrates the sensory information and recruits specific neural pathways to generate appropriate cardiorespiratory responses. Given this significance, it is evident that changes in the normal functioning of the NTS neurons have great impact on the control of sympathetic and respiratory activities with pathological relevance, such as observed in animal models of arterial hypertension (Sato et al., [@B138]; Zhang and Mifflin, [@B162]) and in animals exposed to chronic intermittent hypoxia (Reeves et al., [@B131]; Kline et al., [@B86]; Almado et al., [@B10]). In the following sections, we discuss the potential role of the NTS in coordinating sympathetic and respiratory reflex responses, focusing on the neurotransmission and on the efferent brainstem pathways. The involvement of neural pathways from the NTS to mid- and forebrain regions will not be discussed in this review, since their involvement in the respiratory-sympathetic coupling is not clear.

The NTS and the respiratory-sympathetic coupling during peripheral chemoreflex activation
=========================================================================================

It is well known that prolonged exposure to low partial pressure of arterial oxygen (PaO~2~) may produce persistent changes in the cellular activity leading to tissue dysfunction and death (Peña and Ramirez, [@B125]). To prevent this, a reflex system, named the peripheral chemoreflex, was developed in order to evoke appropriated and coordinated cardiovascular and respiratory responses to counteract the fall in PaO~2~. During hypoxia, the reduction of PaO~2~ is detected by chemosensitive cells, mainly located in the carotid bodies (Lahiri et al., [@B93]), which, in turn, send excitatory inputs to the 2nd-order neurons of the cNTS (Teppema et al., [@B156]; Cruz et al., [@B43]). These cNTS neurons are responsible for the integration and transmission of the peripheral chemoreceptor signals to other brain regions, leading to the emergence of sympathetic, parasympathetic and respiratory reflex responses that increase arterial pressure, reduce heart rate and enhance ventilation, respectively (Haibara et al., [@B70]; Colombari et al., [@B39]; Sapru, [@B137]). Previous studies suggested that the sympatho-excitatory response of the peripheral chemoreflex is dependent on the activation of NTS neurons that send excitatory inputs to the pre-sympathetic neurons of the RVLM (Aicher et al., [@B7]; Koshiya and Guyenet, [@B88]). Studies performed in anesthetized rats (Dick et al., [@B49]; Mandel and Schreihofer, [@B101]) and unanesthetized *in situ* rat preparations (Costa-Silva et al., [@B41]) verified that the peripheral chemoreflex-induced sympathetic response is characterized by the emergence of higher amplitude bursts during post-inspiratory phase followed by inhibition during early inspiration (Figure [1](#F1){ref-type="fig"}). This pattern of sympathetic reflex response occurs entrained with the responses of augmented phrenic burst frequency (increased inspiratory drive) and increased abdominal burst amplitude (active expiration) (Moraes et al., [@B117]). Therefore, it has been suggested that the sympathetic response to peripheral chemoreflex activation exhibit two components: one independent and another dependent on the activation of respiratory neurons (Koshiya and Guyenet, [@B89]; Costa-Silva et al., [@B41]). Recent evidence suggests that the processing and coupling of the sympathetic and respiratory responses of peripheral chemoreflex rely on the recruitment of different neuronal population and/or neurochemical mechanisms in the cNTS (Braga et al., [@B32]; Furuya et al., [@B58]).

Previous studies performed in anesthetized animals proposed that L-glutamate is a major excitatory neurotransmitter released by the peripheral chemoreceptor afferents in the cNTS (Zhang and Mifflin, [@B163]; Sapru, [@B137]; Gozal et al., [@B65]). However, studies performed in unanesthetized rats and in the *in situ* rat preparation failed to block the sympatho-excitatory and respiratory responses elicited by peripheral chemoreceptor activation after the antagonism of both ionotropic and metabotropic glutamatergic receptors (Machado and Bonagamba, [@B97]; Braga and Machado, [@B31]), indicating that neurontransmitters other than L-glutamate mediate the processing of these responses in the cNTS. Afterwards, it was verified that the antagonism of both ionotropic glutamate and P2-purinergic receptors in the cNTS reduced significantly the magnitude of sympathetic response to peripheral chemoreflex activation without affecting the tachypneic response (Braga et al., [@B32]; Braccialli et al., [@B30]). Therefore, the processing of sympathetic chemoreflex response by the cNTS neurons involves a complex interaction between L-glutamate and ATP (Accorsi-Mendonca et al., [@B2]). On the other hand, these neurotransmitters, at the cNTS level, apparently are not essential for the tachypneic reflex response, suggesting the involvement of an additional neurotransmitter system.

Since a functional cholinergic system has been described in the NTS (Ruggiero et al., [@B136]; Shihara et al., [@B145]), our group recently assessed the contribution of acetylcholine (ACh) in the processing of peripheral chemoreflex inputs in the cNTS using the arterially-perfused *in situ* rat preparation. We verified that microinjections of ACh in the cNTS did not change mean levels of sympathetic activity but increased phrenic burst frequency (Furuya et al., [@B58]). In spite of the lack of effects on mean levels of sympathetic activity, microinjections of ACh in the cNTS altered its coupling pattern with the respiratory activity, producing a shift of respiratory-related peak from the inspiratory to the post-inspiratory phase associated with an inhibition during the inspiratory phase (Furuya et al., [@B58])---a pattern similar to that evoked by peripheral chemoreflex activation (Dick et al., [@B49]; Costa-Silva et al., [@B41]). Moreover, the antagonism of nicotinic receptors in the cNTS prevented the ACh-induced tachypnea and significantly reduced the tachypneic response following chemoreflex activation, without affecting the magnitude of sympatho-excitatory response (Furuya et al., [@B58]). In addition, the nicotinic antagonism in the cNTS also prevented the ACh-induced change in sympatho-respiratory coupling (Furuya et al., [@B58]). These data suggest that cholinergic mechanisms of the cNTS, at least in part, contribute to the processing of inspiratory response of the peripheral chemoreflex activation and its entrainment with the sympathetic activity. Recent studies have reported efferent projections from the cNTS to respiratory nuclei of the ventrolateral medulla and dorsolateral pons (Takakura et al., [@B154]; Alheid et al., [@B9]; Song et al., [@B150]) that may be involved with the emergence of respiratory responses of peripheral chemoreflex. However, further studies are still required to elucidate the respiratory nuclei targeted by the cNTS neurons activated by ACh.

Accordingly, the cNTS possesses an intrinsic neuronal circuitry that is essential for the precise coordination of evoked sympathetic and respiratory responses during hypoxia (Figure [2](#F2){ref-type="fig"}). Our recent data (Furuya et al., [@B58]) combined with previous studies (Braga et al., [@B32]), suggest that the respiratory and sympathetic components of peripheral chemoreflex, in unanesthetized conditions, are processed by 2nd-order cNTS neurons activated by different neurotransmitters, including L-glutamate, ATP and ACh. Whether ATP and ACh are released by afferent terminals, likewise L-glutamate, or by other cells of the cNTS (glia or neurons, respectively ATP and ACh) (Accorsi-Mendonca et al., [@B4]) still remain to be elucidated. Nevertheless, the selective activation of the 2nd-order neurons may be essential for the recruitment of specific neural pathways promoting the increase in sympathetic activity mainly during the post-inspiratory phase entrained with the increases in inspiratory and expiratory motor activities. The physiological meaning of the respiratory-sympathetic coupling observed during peripheral chemoreflex activation is not clear and requires further studies to be fully elucidated. Nonetheless, the sympathetic pattern during hypoxia is different from that observed at baseline conditions or during hypercapnia (Molkov et al., [@B114]), suggesting, therefore, that it may play a relevant role in matching oxygen uptake/delivery and tissue perfusion in conditions of low PaO~2~.

![**Schematic drawing showing the possible cellular and neurochemical mechanisms of the cNTS mediating the processing of peripheral chemoreceptors inputs**. The stimulation of peripheral chemoreceptors evokes the release of L-glutamate in the cNTS (Mifflin, [@B109]; Andresen and Kunze, [@B11]). Experimental evidence indicates the L-glutamate, in association with ATP, is essential for the processing of sympatho-excitatory response of the peripheral chemoreflex in the cNTS (Machado and Bonagamba, [@B97]; Braga et al., [@B32]). It is suggested that both glutamatergic and purinergic systems interact and activate cNTS neurons that send projections to pre-sympathetic neurons of the RVLM (Accorsi-Mendonca et al., [@B2], [@B4]). L-glutamate is also proposed to mediate the activation of other neural pathways that are important for the sympatho-excitatory component of peripheral chemoreflex, including those to the A5 region, retrotrapezoid nucleus (RTN), parabrachial nucleus/Kölliker-Fuse complex (PBN/KF) and hypothalamus (Koshiya and Guyenet, [@B87]; Olivan et al., [@B123]; Haibara et al., [@B71]; Reddy et al., [@B130]; Takakura et al., [@B154]; Queiroz et al., [@B128]; Song et al., [@B150]; Taxini et al., [@B155]; King et al., [@B84]). In addition to L-glutamate and ATP, our recent studies suggest that ACh in the cNTS significantly contributes to the tachypnea and the patterning of sympathetic response of peripheral chemoreflex (Furuya et al., [@B58]). We hypothesize that ACh activates cNTS neurons that send projections to respiratory neurons of the ventral medulla that, in turn, promotes the stimulation of inspiratory motor activity and the patterning of sympathetic activity. The latter may involve the modulation of the neurons of RVLM and of the caudal ventrolateral medulla (CVLM) (Mandel and Schreihofer, [@B102]; Moraes et al., [@B120]). However, it remains to be elucidated the sources of ACh in the cNTS as well as the efferent pathways activated by ACh in response to peripheral chemoreflex activation.](fphys-05-00238-g0002){#F2}

The NTS and the processing of cardiovascular and pulmonary feedback information
===============================================================================

The iNTS neurons receive mainly the afferent information from mechanoreceptors located in the arterial blood vessels and pulmonary walls (Mifflin and Felder, [@B110]; Kubin et al., [@B90]). The arterial mechanoreceptors, named as arterial baroreceptors, are located in the aortic arc and carotid artery bifurcation and provide a powerful inhibitory feedback control of sympathetic activity, lowering the sympathetic vascular tonus in conditions of increased arterial pressure (Chan and Sawchenko, [@B35]; Gordon and Sved, [@B63]). This sympatho-inhibitory response is mediated by the activation of excitatory 2nd-order neurons of the NTS that, in turn, promotes the inhibition of RVLM pre-sympathetic neurons through the activation of GABAergic neurons of the CVLM (Aicher et al., [@B6]; Schreihofer and Guyenet, [@B141]). Several pharmacological and electrophysiological studies suggest that the L-glutamate is the main neurotransmitter released by baroreceptor afferents (Reis et al., [@B132]; Bailey et al., [@B17]). However, Machado et al. ([@B98]), reported that the antagonism of ionotropic glutamatergic receptors in the iNTS of awake rats was unable to block totally the hypotensive response to baroreflex activation (induced by electrical stimulation of the aortic depressor nerve), suggesting that the processing of baroreflex afferent information may either involve other regions of the NTS or other neurotransmitter systems than L-glutamate.

In association with the sympatho-inhibitory response, activation of baroreceptors also prolongs expiratory time, reducing the respiratory frequency (Richter and Seller, [@B134]; Lindsey et al., [@B94]; Baekey et al., [@B16]). According to Baekey et al. ([@B16]), the expiratory lengthening induced by arterial baroreceptor activation results from the activation of post-inspiratory neurons of the BötC, which, in turn, inhibit the central inspiratory activity (Smith et al., [@B147]). Since these post-inspiratory neurons may also establish synaptic contacts with the pre-sympathetic neurons of the RVLM (Sun et al., [@B153]), the baroreflex-induced activation of inhibitory post-inspiratory neurons of the BötC may additionally contribute to depress the RVLM neuronal activity (Baekey et al., [@B16]). Besides, with the post-inspiratory activation and the increase in expiratory time, the emergence of inspiratory-related bursts of sympathetic activity is delayed and the sympathetic activity is maintained at low levels. Therefore, in addition to the classical NTS-CVLM-RVLM baroreflex arc, a parallel respiratory-dependent pathway from the NTS to the VRC also contributes to reduce sympathetic activity in conditions of high arterial pressure. It remains to be elucidated whether this respiratory baroreflex pathway relies on the different subset of 2nd-order neurons (for instance, neurons receiving SAR afferent information, as described below) or recruits neurotransmitter other than L-glutamate (Machado et al., [@B98]; Baekey et al., [@B16]).

Mechanoreceptors located mainly in pulmonary walls, including the SARs and RARs, are important to reflexly control the central respiratory command according to lung volume (for further review, see Kubin et al., [@B90]). Although both receptors are sensitive to pulmonary wall distension, the lung inflation feedback control is evoked mainly by SAR afferent inputs (Bonham et al., [@B27]). The vagal afferents from SARs terminates predominantly in the ventrolateral portion of the iNTS (Kalia and Mesulam, [@B82]). In rats, different populations of neurons are suggested to receive the afferent information from SARs: (i) inspiratory neurons that fire during central inspiratory drive and are sensitive to vagal stimulation (either excited or inhibited); (ii) pump cells (P cells) that present action potentials in phase with lung inflation cycle, but not with central inspiratory rhythm, and are activated when lungs are overinflated (Bonham and McCrimmon, [@B28]; De Castro et al., [@B46]). SARs stimulation initiates the Hering-Breuer reflex and promotes the suppression of inspiratory motor activity and prolongs the expiratory phase (Breuer, [@B34]; Hering, [@B77]; Backman et al., [@B14]; Kubin et al., [@B90]). The removal of pulmonary feedback control, through vagotomy, results in large increases of inspiratory amplitude and duration (Kubin et al., [@B90]), evidencing an important role of the SARs feedback information for baseline control of respiratory phase transition and duration.

P cells of the iNTS are thought to be the main cellular source integrating and transmitting the SAR afferent information to pontine and medullary respiratory neurons (McCrimmon et al., [@B107]; Bonham et al., [@B27]; Ezure et al., [@B55]; Molkov et al., [@B113]), leading to the activation of the post-inspiratory neurons of the BötC that, in turn, inhibit the inspiratory neuronal activity (Hayashi et al., [@B76]). By the fact that the antagonism of ionotropic glutamatergic receptors in the iNTS of anesthetized animals greatly attenuates baseline activity of P cells and impairs the Hering-Breuer respiratory reflex responses (Bonham and McCrimmon, [@B28]; Bonham et al., [@B27]), it has been suggested that L-glutamate is the major neurotransmitter release by SAR vagal afferent in the iNTS. Microinjections of glutamatergic agonists into the iNTS excite P cells and promote apnea and expiratory lengthening like Hering-Breuer reflex (Bonham et al., [@B27]; Gourine et al., [@B64]), corroborating the idea that L-glutamate is released by SAR afferent inputs in the iNTS. In addition to L-glutamate, there is evidence that other neurotransmitters may play a role in the processing of pulmonary afferent information at the level of iNTS. Studies by Gourine et al. ([@B64]) demonstrated that the concentrations of ATP and L-glutamate in the iNTS increase in phase to lung inflation and independently on central respiratory drive, suggesting that SAR afferents may release both neurotransmitters. Also, injections of ATP in the iNTS mimic the respiratory responses induced by lung inflation (Antunes et al., [@B13]; Gourine et al., [@B64]) and the antagonism of purinergic receptors significantly reduced basal activity of P cells (Gourine et al., [@B64]). These results suggest that an interaction between glutamatergic and purinergic systems may mediate the processing of pulmonary feedback information at the level of iNTS.

Lung inflation also elicits a decrease in sympathetic activity and vasodilation in addition to the respiratory responses (Gerber and Polosa, [@B60]; Sellden et al., [@B142]; Yu et al., [@B160]), suggesting a possible correlation between the respiratory and sympathetic responses to SAR activation. Since L-glutamate is suggested to be the major neurotransmitter release by SAR afferents (Bonham et al., [@B27]), it is possible to speculate that glutamatergic activation of P cells also mediates the reduction of sympathetic activity associated with expiratory prolongation. In agreement with that, studies have demonstrated that microinjections of L-glutamate in the iNTS produce coupled inspiratory inhibition, expiratory lengthening and sympatho-inhibition (Berger et al., [@B23]; Marchenko and Sapru, [@B103]). Alternatively, it is possible that the sympathetic and inspiratory inhibitory responses to lung inflation rely on interactions with neurons that are part of the baroreflex pathway, which are also located in the iNTS and are activated by L-glutamate (Bailey et al., [@B17]). Both possibilities, although not proven experimentally, indicate that the iNTS possesses a complex neuronal circuitry that is important to coupled respiratory and sympathetic responses to cardiorespiratory mechanoreceptor activation.

We recently verified that microinjections of ACh in the iNTS reduce phrenic burst frequency, due to an increase in expiratory time, associated with reductions in sympathetic activity (Furuya et al., [@B58]). Interestingly, this cholinergic system of the iNTS apparently is not involved in the processing of the baroreflex responses because the antagonism of cholinergic receptors in the iNTS did not prevent the sympathetic and respiratory responses elicited by increase in pressure (Furuya et al., [@B58]). These findings suggest that the cholinergic neurotransmission in the iNTS may also contribute to the processing of respiratory and sympathetic responses of Hering-Breuer reflex. Nonetheless, this possibility still requires further experiments to be proven.

Therefore, the respiratory and sympathetic changes induced by Hering-Breuer activation may involve the release/co-release of distinct neurotransmitters, which may interact and activate either excitatory or inhibitory P cells (Kubin et al., [@B90]) or different neuronal populations (P cells and baroreflex sensitive neurons) within the iNTS.

NTS neuroplasticity and the development of cardiorespiratory dysfunctions
=========================================================================

In response to intensive stimuli, the afferents and neurons of the NTS may exhibit plastic changes (Zhou et al., [@B165]; Chen et al., [@B37]; Kline, [@B85]) that, in turn, modify the control of respiratory and sympathetic activities. Depending on the degree of plasticity, the changes in the NTS neuronal activity may persist and contribute to the development and/or maintenance of cardiorespiratory dysfunctions. This may be the case of pathological conditions associated with potentiation of peripheral chemoreflex responses and sympathetic overactivity (Narkiewicz et al., [@B121]; Niewinski et al., [@B122]). Therefore, the understanding of the mechanisms promoting plastic changes in the NTS circuitry associated with pathological conditions may help to develop potential therapeutic venues to treat cardiorespiratory diseases, as discussed below.

Neurogenic hypertension
-----------------------

There is compelling evidence indicating that hyperactivity of the sympathetic nervous system is an important mechanism producing the chronic elevation of arterial pressure in hypertensive patients (Staessen et al., [@B152]), especially those that are resistant to concurrent anti-hypertensive treatment (Esler, [@B54]). Recent studies indicate that the surgical removal of the carotid body peripheral chemoreceptors of juvenile (4-week old) spontaneous hypertensive rats (SHR), an experimental model for neurogenic hypertension, attenuates the development of hypertension (Abdala et al., [@B1]). In adult SHR rats (12-week old), the carotid body denervation significantly reduces arterial pressure and renal sympathetic nerve activity levels (McBryde et al., [@B106]). The high levels of sympathetic activity in SHRs exhibit an amplified respiratory-sympathetic coupling, with augmented sympathetic activity mainly during the inspiratory phase (Czyzyk-Krzeska and Trzebski, [@B44]; Simms et al., [@B146]) that is also reduced with the removal of carotid body chemoreceptors (McBryde et al., [@B106]). Based on that, it has been proposed that heightened peripheral chemoreceptor activity contributes to elevate baseline levels of sympathetic activity and magnify the respiratory modulation of sympathetic activity in SHR rats. Studies by Sato et al. ([@B139]) have shown that lesions of the cNTS also produce a significant fall in the arterial pressure level in adult SHR, but not in normotensive rats, suggesting that the development of hypertension in this model may involve neuroplasticity within the NTS. In agreement with this hypothesis, there are several studies demonstrating relevant changes in the mechanisms of neurotransmission and neuromodulation in the NTS of SHR rats, including glutamate (Aicher et al., [@B8]), angiontesin II (Shan et al., [@B143]), GABA (Mei et al., [@B108]; Spary et al., [@B151]), nitric oxide (Hirooka et al., [@B78]) and inflammatory molecules (Waki et al., [@B159]). Altogether, these findings indicate that neurogenic hypertension is causally associated with potentiation of peripheral chemoreflex, in which plastic changes of cNTS neurons receiving the afferent inputs from the carotid bodies importantly contribute to elevate baseline sympathetic activity and strength respiratory-sympathetic coupling. The contribution of amplified respiratory-sympathetic coupling for the development and maintenance of arterial hypertension in SHR rats is still under investigation and is matter of debate (Fatouleh and Macefield, [@B56]; Moraes et al., [@B118]).

Chronic intermittent hypoxia
----------------------------

Sensitization of the peripheral chemoreflex is observed in patients suffering obstructive sleep apnea (OSA). Due to recurrent collapses of upper airways, OSA patients frequently experience intermittent episodes of hypoxia during sleep (Dempsey et al., [@B47]). Overtime, untreated OSA patients develop arterial hypertension associated with high levels of sympathetic activity (Somers, [@B149]) and tonic chemoreflex activation (Narkiewicz et al., [@B121]). In rodent models, the exposure to chronic intermittent hypoxia (CIH) causes a sustained increase in baseline arterial pressure that is prevented by carotid body denervation (Fletcher et al., [@B57]). The hypertension induced by CIH in rats is associated with high levels of baseline sympathetic activity (Zoccal et al., [@B166], [@B168], [@B167]), enhanced baseline frequency of discharge of RVLM pre-sympathetic neurons (Moraes et al., [@B116]), augmented peripheral chemoreflex responses (Peng et al., [@B126]; Rey et al., [@B133]; Braga et al., [@B33]), changes in the respiratory pattern and strengthened respiratory-sympathetic coupling (Zoccal et al., [@B168]). Therefore, intermittent activation of the peripheral chemoreceptors, as observed in OSA patients, introduces persistent changes in the neural pathways of peripheral chemoreflex that culminate with the development of cardiorespiratory dysfunctions.

With respect to the NTS, studies *in vitro* evidenced that AMPA-evoked currents of isolated 2nd-order neurons of the cNTS are enhanced in rats exposed to CIH (De Paula et al., [@B48]). Our previous studies demonstrated that CIH rats exhibit augmented sympatho-excitatory and blunted phrenic apneic responses to microinjections of L-glutamate in the cNTS in association with increased densities of NMDA and non-NMDA receptor subunities within the cNTS (Costa-Silva et al., [@B42]). Altogether, these studies indicate that CIH exposure promotes functional changes in the glutamatergic neurontrasmission in the cNTS. In addition to the glutamatergic mechanisms, Zhang et al. ([@B161]) reported that the outward currents mediated by ATP-sensitive potassium channels (K~ATP~) of 2nd-order neurons of the peripheral chemoreceptors of CIH rats are reduced---a fact that may increase the excitability of these neurons. Accordingly, CIH exposure appears to alter post-synaptic mechanisms in neurons of the cNTS, amplifying the excitatory responses to glutamatergic receptor activation.

Kline et al. ([@B86]) have also documented that neurons of the cNTS of rats submitted to CIH exhibit a higher basal frequency of discharge due to an augmented spontaneous neurotransmitter release by pre-synaptic terminals. Therefore, increased spontaneous neurotransmitter release combined with amplified post-synaptic glutamatergic excitatory responses may represent an important mechanism producing enhanced basal and evoked activity of cNTS neurons after CIH. As a consequence, higher excitatory drive is transmitted to downstream sympathetic and respiratory chemoreflex pathways, which contribute, at least in part, to the development of cardiorespiratory dysfunctions associated with CIH exposure. So far, there are no studies elucidating the involvement of other neurotransmitters or neuromodulators of the cNTS (for instance ATP or ACh) in the context of CIH. This represents important possibilities to better understand the contribution of the cNTS mechanisms to elevate baseline sympathetic activity or modify the respiratory pattern and the respiratory-sympathetic coupling in CIH rats, since the overactivity of RVLM pre-sympathetic neurons induced by CIH mainly depends on synaptic inputs rather than changes in their intrinsic properties (Moraes et al., [@B116]).

Obesity
-------

Additionally to the classical neurochemical mechanisms, there is evidence that peripheral molecules interfere with the activity of the NTS neurons and then modify sympathetic and respiratory activities. This peripheral-central crosstalk appears to have significance in the context of the cardiovascular dysfunctions related to obesity. Obese individuals may develop arterial hypertension associated with high levels of sympathetic activity (Hall et al., [@B72]), by mechanisms not completely understood. Adipocytes are considered as an endocrine tissue producing several substances including interleukin-6, tumor necrosis factors-α, adiponectin and leptin (Kershaw and Flier, [@B83]; Galic et al., [@B59]). Attention has been given to the effects of leptin on the central mechanisms controlling autonomic and respiratory activities. In addition to its central effects suppressing appetite (Grill, [@B66]), it was shown that leptin exerts excitatory effects on central nuclei controlling sympathetic (Rahmouni et al., [@B129]; Mark et al., [@B104]) and respiratory activities (Inyushkina et al., [@B80]; Malli et al., [@B99]; Bassi et al., [@B21], [@B20]; Chang et al., [@B36]), increasing baseline sympathetic activity and stimulating breathing. By the fact that leptin levels are enhanced in obese subjects (Considine et al., [@B40]), this hormone can be considered as a relevant candidate acting on central nervous system and contributing to the cardiovascular changes associated with obesity.

Systemic administration of leptin has been shown to increase *c-fos* expression in neurons of the cNTS (Elmquist et al., [@B53]; Elias et al., [@B52]) and enhance phrenic burst amplitude (Chang et al., [@B36]). Morevoer, microinjections of leptin in the NTS increase renal sympathetic activity (Mark et al., [@B104]) and ventilation (Inyushkin et al., [@B79]). Therefore, the NTS is a potential target for action of circulating leptin. Importantly, both obesity and high leptin levels have been observed in OSA patients, who present a high risk to develop arterial hypertension than non-obese OSA patients (Schafer et al., [@B140]; Harsch et al., [@B73]; Patel et al., [@B124]). Therefore, a positive interaction between intermittent hypoxia, peripheral chemoreflex activation and leptin effects may be considered. In this regard, it was reported that the sympatho-excitatory responses induced by either activation of peripheral chemoreceptors or microinjections of L-glutamate in the cNTS are potentiated by previous microinjections of leptin in the cNTS (Ciriello and Moreau, [@B38]). Thus leptin enhances the sympatho-excitatory responses to peripheral chemoreflex activation through its actions on cNTS neurons involved with the processing of peripheral chemoreceptor inputs. The effects of leptin on the chemoreflex-induced respiratory response and on respiratory-sympathetic coupling are still to be determined.

Concluding remarks
==================

Although the precise physiological meaning of the respiratory-sympathetic coupling in different conditions (resting, metabolic challenges and physical exercise) is still under debate (Hayano et al., [@B75]; Ben-Tal et al., [@B22]), there is evidence showing that modifications in the central mechanisms underlying the interactions between respiratory and sympathetic neurons are associated with the development of sympathetic overactivity (Zoccal et al., [@B168]; Simms et al., [@B146]; Toney et al., [@B157]). In this regard, the identification of neuronal sources and targets as well as the corresponding neurochemical mechanisms underlying the respiratory-sympathetic coupling is required for a better comprehension of this phenomenon and its pathological implications. In addition to ventral medullary neurons, the NTS neurons play an essential role in coordinating respiratory and sympathetic adjustments in response to activation of peripheral cardiovascular and pulmonary afferent inputs, such as the baroreceptors, the pulmonary stretch receptors and especially the peripheral chemoreceptors. Due to its afferent-based organization, neurons of specific sub-regions of the NTS may respond to different stimuli and generate specific patterns of responses due to the recruitment of specific downstream sympathetic and respiratory pathways.
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